LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Prenatal vs postnatal diagnosis of 22q11.2 deletion syndrome: cardiac and noncardiac outcomes through 1 year of age.

Freud, Lindsay R / Galloway, Stephanie / Crowley, T Blaine / Moldenhauer, Julie / Swillen, Ann / Breckpot, Jeroen / Borrell, Antoni / Vora, Neeta L / Cuneo, Bettina / Hoffman, Hilary / Gilbert, Lisa / Nowakowska, Beata / Geremek, Maciej / Kutkowska-Kaźmierczak, Anna / Vermeesch, Joris R / Devriendt, Koen / Busa, Tiffany / Sigaudy, Sabine / Vigneswaran, Trisha /
Simpson, John M / Dungan, Jeffrey / Gotteiner, Nina / Gloning, Karl-Philipp / Digilio, Maria Cristina / Unolt, Marta / Putotto, Carolina / Marino, Bruno / Repetto, Gabriela / Fadic, Magdalena / Garcia-Minaur, Sixto / Achón Buil, Ana / Thomas, Mary Ann / Fruitman, Deborah / Beecroft, Taylor / Hui, Pui Wah / Oskarsdottir, Solveig / Bradshaw, Rachael / Criebaum, Amanda / Norton, Mary E / Lee, Tiffany / Geiger, Miwa / Dunnington, Leslie / Isaac, Jacqueline / Wilkins-Haug, Louise / Hunter, Lindsey / Izzi, Claudia / Toscano, Marika / Ghi, Tullio / McGlynn, Julie / Romana Grati, Francesca / Emanuel, Beverly S / Gaiser, Kimberly / Gaynor, J William / Goldmuntz, Elizabeth / McGinn, Daniel E / Schindewolf, Erica / Tran, Oanh / Zackai, Elaine H / Yan, Qi / Bassett, Anne S / Wapner, Ronald / McDonald-McGinn, Donna M

American journal of obstetrics and gynecology

2023  Volume 230, Issue 3, Page(s) 368.e1–368.e12

Abstract: Background: The 22q11.2 deletion syndrome is the most common microdeletion syndrome and is frequently associated with congenital heart disease. Prenatal diagnosis of 22q11.2 deletion syndrome is increasingly offered. It is unknown whether there is a ... ...

Abstract Background: The 22q11.2 deletion syndrome is the most common microdeletion syndrome and is frequently associated with congenital heart disease. Prenatal diagnosis of 22q11.2 deletion syndrome is increasingly offered. It is unknown whether there is a clinical benefit to prenatal detection as compared with postnatal diagnosis.
Objective: This study aimed to determine differences in perinatal and infant outcomes between patients with prenatal and postnatal diagnosis of 22q11.2 deletion syndrome.
Study design: This was a retrospective cohort study across multiple international centers (30 sites, 4 continents) from 2006 to 2019. Participants were fetuses, neonates, or infants with a genetic diagnosis of 22q11.2 deletion syndrome by 1 year of age with or without congenital heart disease; those with prenatal diagnosis or suspicion (suggestive ultrasound findings and/or high-risk cell-free fetal DNA screen for 22q11.2 deletion syndrome with postnatal confirmation) were compared with those with postnatal diagnosis. Perinatal management, cardiac and noncardiac morbidity, and mortality by 1 year were assessed. Outcomes were adjusted for presence of critical congenital heart disease, gestational age at birth, and site.
Results: A total of 625 fetuses, neonates, or infants with 22q11.2 deletion syndrome (53.4% male) were included: 259 fetuses were prenatally diagnosed (156 [60.2%] were live-born) and 122 neonates were prenatally suspected with postnatal confirmation, whereas 244 infants were postnatally diagnosed. In the live-born cohort (n=522), 1-year mortality was 5.9%, which did not differ between groups but differed by the presence of critical congenital heart disease (hazard ratio, 4.18; 95% confidence interval, 1.56-11.18; P<.001) and gestational age at birth (hazard ratio, 0.78 per week; 95% confidence interval, 0.69-0.89; P<.001). Adjusting for critical congenital heart disease and gestational age at birth, the prenatal cohort was less likely to deliver at a local community hospital (5.1% vs 38.2%; odds ratio, 0.11; 95% confidence interval, 0.06-0.23; P<.001), experience neonatal cardiac decompensation (1.3% vs 5.0%; odds ratio, 0.11; 95% confidence interval, 0.03-0.49; P=.004), or have failure to thrive by 1 year (43.4% vs 50.3%; odds ratio, 0.58; 95% confidence interval, 0.36-0.91; P=.019).
Conclusion: Prenatal detection of 22q11.2 deletion syndrome was associated with improved delivery management and less cardiac and noncardiac morbidity, but not mortality, compared with postnatal detection.
MeSH term(s) Infant ; Infant, Newborn ; Pregnancy ; Female ; Humans ; Male ; DiGeorge Syndrome/diagnosis ; DiGeorge Syndrome/genetics ; Retrospective Studies ; Prenatal Diagnosis ; Heart Defects, Congenital/diagnosis ; Heart Defects, Congenital/epidemiology ; Heart Defects, Congenital/genetics ; Prenatal Care
Language English
Publishing date 2023-09-16
Publishing country United States
Document type Journal Article
ZDB-ID 80016-8
ISSN 1097-6868 ; 0002-9378
ISSN (online) 1097-6868
ISSN 0002-9378
DOI 10.1016/j.ajog.2023.09.005
Shelf mark
Um I Zs.152: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top